The study results on Leqembi, which Eisai shares with Biogen, also found that Alzheimer’s patients who take the therapy get worse after they stop treatment.
More Stories
Pixelverse debuts TON Microtransactions outside Telegram with beta browser game launch
Pixelverse launches a closed beta MMORPG browser game with TON microtransactions. The game marks the first TON integration outside Telegram,...
Tether invests $1.5 million in Sorted Wallet
Tether announced its $1.5 million strategic investment in Sorted Wallet on Sept. 19. Sorted Wallet will tap into this investment...
Five Reasons why Telegram gaming could be 2025’s breakout success
Telegram’s mobile-first approach boosts tap-to-earn game popularity in emerging markets. Ease of access through channels and built-in wallets attracts new...
New government legislation could open up sports betting in Alberta, Canada by end of this year
Alberta’s Bill 16 will allow third-party operators in online gambling by 2025 The province aims to capture grey market bets...
August home sales drop more than expected, as prices set a new record
The median price of an existing home sold in August was $416,700, up 3.1% from August 2023.
UAW warns of potential strikes at Ford, Stellantis a year after unprecedented work stoppages
The UAW has announced a strike deadline at a Ford tool and die plant that supports F-150 production as well...